BALDONI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 669
EU - Europa 483
AS - Asia 246
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.399
Nazione #
US - Stati Uniti d'America 669
SE - Svezia 152
IE - Irlanda 124
CN - Cina 114
TR - Turchia 67
SG - Singapore 56
IT - Italia 48
DE - Germania 42
UA - Ucraina 37
GB - Regno Unito 34
FR - Francia 16
BE - Belgio 14
FI - Finlandia 11
IN - India 4
VN - Vietnam 2
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
JP - Giappone 1
MY - Malesia 1
NL - Olanda 1
RO - Romania 1
RU - Federazione Russa 1
Totale 1.399
Città #
Jacksonville 144
Chandler 127
Dublin 124
Ann Arbor 62
Singapore 48
Boardman 43
Izmir 34
Nanjing 32
Woodbridge 30
Wilmington 23
Ashburn 18
Lawrence 18
Princeton 18
Santa Clara 18
San Mateo 17
Brussels 14
New York 12
Nanchang 11
Verona 11
Hangzhou 10
L'aquila 10
Perugia 7
Hebei 6
Milan 6
Mountain View 6
Shenyang 6
Jiaxing 5
Lanzhou 5
Los Angeles 5
Ningbo 5
Des Moines 4
Falls Church 4
Zhengzhou 4
Kunming 3
L’Aquila 3
Tianjin 3
Auburn Hills 2
Changsha 2
Dallas 2
Dearborn 2
Dong Ket 2
Düsseldorf 2
Fremont 2
Fuzhou 2
Jinan 2
Redwood City 2
Seattle 2
Shanghai 2
Taizhou 2
Amsterdam 1
Beijing 1
Bremen 1
Gandhi Nagar 1
Guangzhou 1
Helsinki 1
Houston 1
Jinhua 1
Kuala Lumpur 1
Leeds 1
Madrid 1
Munich 1
Olomouc 1
Philadelphia 1
Prato 1
Pune 1
San Giovanni in Persiceto 1
Strasbourg 1
Taiyuan 1
Tokyo 1
Totale 942
Nome #
Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT 103
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 101
Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models 91
Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma? 90
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 88
Constitutive phosphorilation of the active Notch1 intracellular domain in chronic lymphocytic leukemia with Notch1 mutation 87
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 83
Notch1 modulates MSC-mediated regulatory T cell induction 77
Notch1 PEST domain mutation is an adverse prognostic factor in B-CLL 75
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 75
NOTCH signalling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 75
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation 73
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 73
T regulatory cell separation for clinical application 71
The NOTCH1/CD39 axis: a Treg trip-switch for GvHD. 71
A revised Notch1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 66
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 64
Notch and NF-kB interplay in Chronic Lymphocytic Leukemia is independent of genetic lesion 52
Totale 1.415
Categoria #
all - tutte 5.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020113 0 0 0 0 2 20 47 3 18 5 0 18
2020/2021193 6 18 0 25 20 15 25 1 18 21 27 17
2021/2022191 20 8 72 22 5 3 5 9 5 9 6 27
2022/2023374 27 29 5 45 35 31 0 25 158 1 13 5
2023/202466 9 5 1 9 3 14 0 15 0 3 5 2
2024/2025102 21 5 30 4 42 0 0 0 0 0 0 0
Totale 1.415